# FDA recall D-607-2013

> **Pfizer Inc** · Class III · drug recall initiated 2013-05-31.

## Product

Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.

## Reason for recall

Failed Dissolution Specification

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-607-2013
- **Recalling firm:** Pfizer Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-31
- **Report date:** 2013-06-26
- **Termination date:** 2015-06-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Peapack, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-607-2013

## Citation

> AI Analytics. FDA recall D-607-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-607-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*